|
Delayed
Bombay S.E.
00:11:55 2026-09-30 EDT
|
5-day change | 1st Jan Change | ||
| 2,179.60 INR | +0.97% |
|
-2.97% | +36.91% |
| 07-30 | Hester Biosciences Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| 07-30 | Hester Biosciences Limited, Q1 2027 Earnings Call, Jul 30, 2026 |
| Market Cap | 18.36B 191M 169M 160M 145M 272M 274M 1.92B 739M 9.38B 719M 703M 30.18B | P/E 2025 |
38.8x | P/E 2026 | 19.3x |
|---|---|---|---|---|---|
| Enterprise Value | 20.25B 211M 186M 176M 160M 300M 302M 2.11B 815M 10.34B 792M 775M 33.27B | EV / Sales 2025 |
4.11x | EV / Sales 2026 | 3.78x |
| Free-Float |
31.22% | Yield 2025 |
0.56% | Yield 2026 | 0.87% |
Bombay S.E.INR
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| HESTERBIO | Delayed | |
NSE India S.E.
| HESTERBIO | Delayed |
Last Transcript: Hester Biosciences Limited
| 1 day | +0.97% | ||
| 1 week | -2.97% | ||
| Current month | -3.53% | ||
| 1 month | -3.53% | ||
| 3 months | +0.84% | ||
| 6 months | +72.62% | ||
| Current year | +36.91% |
| 1 week | 2,104.25 |  | 2,232.5 |
| 1 month | 2,104.25 | | 2,524.9 |
| Current year | 1,250.95 | | 2,669 |
| 1 year | 1,250.95 | | 2,669 |
| 3 years | 1,246.75 | | 3,375.45 |
| 5 years | 1,246.75 | | 3,375.45 |
| 10 years | 666 | | 3,375.45 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 64 | 1987-04-28 | |
Ashish Desai
DFI | Director of Finance/CFO | - | 2025-11-19 |
Vinod Mali
CMP | Compliance Officer | - | 2018-05-13 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 83 | 2005-04-20 | |
| Director/Board Member | 64 | 1987-04-28 | |
| Director/Board Member | 61 | 1987-04-28 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.97% | -2.97% | +15.16% | +31.93% | 190M | |
| -1.58% | -3.51% | -50.86% | -59.59% | 29.52B | |
| +0.71% | -1.40% | +15.30% | +101.16% | 11.22B | |
| +0.12% | -4.16% | -14.33% | -2.18% | 3.7B | |
| +0.98% | +0.98% | -1.11% | +21.29% | 2.93B | |
| -1.24% | +1.27% | +25.61% | +50.38% | 1.93B | |
| +0.18% | -2.47% | +20.57% | +21.47% | 1.85B | |
| -0.70% | +0.85% | -9.45% | +177.60% | 1.45B | |
| -0.30% | -4.18% | -21.28% | -9.74% | 1.12B | |
| -0.45% | -1.48% | -6.74% | -41.19% | 1.01B | |
| Average | -0.13% | -1.62% | -2.71% | +29.11% | 5.49B | |
| Weighted average by Cap. | -0.71% | -2.54% | -24.39% | -4.04% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 3.12B 32.56M 28.74M 27.19M 24.66M 46.23M 46.69M 326M 126M 1.6B 122M 120M 5.13B | 3.34B 34.82M 30.73M 29.07M 26.37M 49.43M 49.92M 349M 134M 1.71B 131M 128M 5.49B |
| Net income | 275M 2.86M 2.53M 2.39M 2.17M 4.07M 4.11M 28.69M 11.06M 140M 10.76M 10.52M 452M | 556M 5.8M 5.12M 4.84M 4.39M 8.23M 8.31M 58.08M 22.38M 284M 21.77M 21.3M 914M |
| Net Debt | 2.16B 22.55M 19.9M 18.83M 17.08M 32.02M 32.33M 226M 87.06M 1.1B 84.68M 82.84M 3.56B | 1.88B 19.62M 17.31M 16.38M 14.86M 27.85M 28.13M 197M 75.74M 961M 73.67M 72.07M 3.09B |
Employees
483
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-30 | ₹2,179.60 | +0.97% | 8 |
| 26-09-29 | ₹2,158.60 | +0.86% | 396 |
| 26-09-28 | ₹2,140.15 | -2.01% | 107 |
| 26-09-25 | ₹2,184.00 | -0.74% | 32 |
| 26-09-24 | ₹2,200.25 | -2.05% | 53 |
- Stock Market
- Stocks
- HESTERBIO Stock
Select your edition
All financial news and data tailored to specific country editions
